Product Information
HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET is a generic product labeled by SpecGx LLC, priced at $0.1384 per EA under NDC 00406012323. Its NADAC has been published 549 times since Feb 17, 2016.
FDA first approved this application on Oct 20, 2000. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 5 mg/1; mg/1
Manufacturer
SpecGx LLCNDC
00406012323
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA040409FDA Approved
10/20/2000
TE Code
AA
On Market Since
10/20/2000
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has been published 549 times since Feb 17, 2016, and over the history we have for it it has declined 7.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1384 per EA |
|---|---|
| All-time high | $0.1518 (Jul 10, 2024) |
| All-time low | $0.0764 (Nov 20, 2019) |
| 52-week high | $0.1388 |
| 52-week low | $0.1273 |
| Median price | $0.1091 |
| Average price | $0.1128 |
| Largest weekly change | +33.6% (Jan 22, 2020) |
| Weeks tracked | 549 |
| Tracking since | Feb 17, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET, manufactured by SpecGx LLC, is $0.1384 per EA (NDC 00406012323), effective Aug 19, 2026.
How has the price of HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has declined 7.1%. It has been tracked across 549 weekly CMS publications since Feb 17, 2016.
What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?
Since Feb 17, 2016, the NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has ranged from a low of $0.0764 (Nov 20, 2019) to a high of $0.1518 (Jul 10, 2024), with a median of $0.1091 per EA.
Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET, is $0.1276 per EA — about 8% below HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET.
Who manufactures HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?
HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET (NDC 00406012323) is labeled by SpecGx LLC, and CMS classifies it as a generic product.